How Does Chymotrypsin Work for Reducing Inflammation, And Is It Effective?

What is Chymotrypsin?​

Chymotrypsin is a serine protease enzyme primarily synthesized in the pancreas as an iNACtive precursor called chymotrypsinogen. Once released into the small intestine, it’s activated by another enzyme and takes on its key role: breaking down dietary proteins into smaller peptides and amino acids. Specifically, it cleaves peptide bonds adjacent to aromatic amino acids like phenylalanine and tyrosine—this precise protein - cutting ability is the foundation of its biological functions, including its potential anti - inflammatory effects.​

Beyond its natural role in digestion, Chymotrypsin has been isolated and studied for decades in medical and cosmetic fields. It’s available in various forms, such as oral supplements, injectables for clinical use, and purified extracts for skincare formulations.​

How Does Chymotrypsin Work to Reduce Inflammation?​

• Breaking Down Inflammatory Proteins

At the site of inflammation, the body releases "pro - inflammatory proteins"—such as bradykinin and fibrin. Chymotrypsin’s ability to cleave specific peptide bonds allows it to break down these proteins, reducing the "building blocks" of inflammation.​

A landmark study published in the Journal of Ethnopharmacology (2018, Volume 225, Pages 128 - 135) tested Chymotrypsin’s effects on acute inflammation in rats. Researchers induced paw swelling and administered Chymotrypsin at doses of 5, 18, and 36 mg/kg. The results showed a dose - dependent reduction in swelling: the 36 mg/kg dose reduced inflammation by 47% after 4 hours, compared to just 18% in the control group. The study concluded that Chymotrypsin directly degrades inflammatory peptides like bradykinin, "starving" the inflammatory response.​

• Modulating the Immune Response​

Inflammation is also driven by immune cells and signaling molecules called cytokines. Chymotrypsin can regulate this immune cascade by altering how these cells and molecules behave.​

A study in the Journal of Neuroimmunology (2020, Volume 347, Article 577320) explored Chymotrypsin’s role in experimental autoimmune encephalomyelitis—a mouse model of multiple sclerosis, a chronic inflammatory disease. Researchers injected 0.2 mg/ml Chymotrypsin directly into the cerebrospinal fluid of EAE - induced mice. After 14 days, the mice showed a 52% reduction in clinical symptoms compared to the untreated group. Further analysis revealed that Chymotrypsin reduced the number of pro - inflammatory macrophages in the brain and spinal cord, and lowered levels of the cytokine TNF - α by 38%. This suggests it doesn’t just "put out the fire" of inflammation—it also calms the immune system’s overreaction.​

Is Chymotrypsin Effective in Reducing Inflammation?​

• Efficacy in Acute and Sub - Acute Inflammation​

The 2018 Journal of Ethnopharmacology study also tested Chymotrypsin in a sub - acute inflammation model. In this case, Chymotrypsin reduced swelling by 58% over 10 days—outperforming aspirin, which only reduced swelling by 32%. The researchers noted that Chymotrypsin’s advantage lies in its ability to target both inflammatory proteins and immune cells, whereas aspirin primarily blocks pain - signaling enzymes.​

• Clinical Use in Post - Injury and Surgical Recovery​

In human clinical settings, Chymotrypsin is often used to reduce swelling after injuries or surgery. A small study published in the Journal of Orthopaedic Surgery and Research (2019, Volume 14, Article 216) tested a combination of oral Chymotrypsin and trypsin in 50 patients with hand fractures. Patients took 500 mg of the enzyme mixture twice daily for 2 weeks. By the end of the study, swelling in the injured hand was reduced by 41% on average, compared to 22% in the placebo group. Patients also reported less pain and faster range of motion recovery.​

• Safety in Medical Applications​

Chymotrypsin’s safety profile is another key advantage. In cataract surgery, it’s used to dissolve the protein - rich "zonule", allowing surgeons to remove the lens more easily. A review in the British Journal of Ophthalmology (2021, Volume 105, Pages 1623 - 1628) analyzed data from 1,200 cataract patients who received Chymotrypsin during surgery. Only 2.3% reported mild side effects, and there were no cases of severe complications like retinal damage. This highlights its safety even in delicate medical procedures.​

Chymotrypsin in the Cosmetic Field: Applications and Benefits​

Key Cosmetic Benefits​

Strengthens the Skin Barrier: The skin’s outermost layer (stratum corneum) is made of keratin, a tough protein. Chymotrypsin, in low concentrations (0.1–0.5% in formulations), gently breaks down damaged keratin fragments, allowing new, healthy skin cells to surface. This process strengthens the skin barrier—critical for protecting against environmental stressors like UV rays, pollution, and dry weather. A 2022 in - vitro study by the International Journal of Cosmetic Science (Volume 44, Pages 389 - 396) found that skin cells treated with 0.3% Chymotrypsin had a 27% increase in ceramide production compared to untreated cells.​

Soothes Sensitive, Inflamed Skin: Its anti - inflammatory properties translate to skincare by reducing redness and irritation. Many brands use Chymotrypsin in products for sensitive or acne - prone skin.

Improves Texture and Hydration: By gently exfoliating dead skin cells, Chymotrypsin leaves skin smoother. A 2021 study in the Journal of Cosmetic Dermatology (Volume 20, Pages 2874 - 2881) found that a moisturizer with 0.4% Chymotrypsin increased skin hydration by 32% after 1 week and reduced rough texture by 29% after 2 weeks, compared to a standard moisturizer.​

Common Cosmetic Formulations​

Chymotrypsin is most often found in:​

• Serums: For targeted redness relief (often paired with hyaluronic acid for hydration).​
• Moisturizers: For barrier repair.​
• Gentle Exfoliants: As a "chemical exfoliant" alternative to AHAs or BHAs.​
• After - Sun Products: To reduce UV - induced redness and inflammation.​

Conclusion​

Chymotrypsin is more than just a digestive enzyme—it’s a versatile agent with proven anti - inflammatory effects, supported by decades of scientific research. Its ability to break down inflammatory proteins and modulate the immune system makes it effective for acute inflammation and potentially useful for chronic conditions. In cosmetics, it offers a gentle, science - backed way to strengthen the skin barrier, soothe irritation, and improve texture.​

As research continues—especially large - scale human trials for chronic inflammatory diseases—Chymotrypsin may become an even more widely used alternative to traditional anti - inflammatory drugs and harsh skincare ingredients. For now, its combination of efficacy, safety, and versatility makes it a promising option for anyone seeking natural solutions to inflammation and skin health.

• Name: Yuik
• E-mail: sales02@nahanutri.com
• WhatsApp：+8618066950297